MTOR and breast neoplasm: The percentages of positive expression for p-ER, EGFR, p-ERK1/2, p-mTOR and IGF1R were also in line with previous published data, using similar population selection, IHC methods, and assessment criteria in primary invasive breast tumors [26, 27, 29, 35, 42].